Front Door Health, a Chicago-based organization that provides in-home addiction and mental health treatment, entered into a joint venture with Northbrook-based MD Infusions to launch a first-of-its kind in-home ketamine treatment program called K3. The collaboration will allow the partners to continue to scale, expand, and diversify their service offerings and meet rapidly increasing demand for in-home health care services.
Front Door Health is a behavioral health care company that delivers in-home addiction and mental health treatment to help consumers recover from addiction. Front Door Health provides consumers with 24/7 access to a multidisciplinary team lead by a primary care professional. The team delivers a highly personalized and adaptive treatment experience using data analytics and machine learning to adjust treatment in real-time.
MD Infusions provides state-of-the-art ketamine infusion therapy. MD Infusions’ expert team of primary care professionals and nurses has many years of experience administering intravenous ketamine. MD Infusions’ protocols follow the latest research and consensus guidelines. All in-home infusions are monitored in person by a primary care professional and nurse, delivering this revolutionary new treatment option in the comfort of home while maintaining the high standards employed at the MD Infusions clinic.
This was reported by Front Door Health on January 5, 2022.
Contact information: Front Door Health, 4610 North Clark Street, Chicago, Illinois 60640; 773-747-5500; Email: info@frontdoorhealthcenter.com; Website: https://www.frontdoorhealthcenter.com/
Contact information: MD Infusions, 666 Dundee Road, Suite 1903, Northbrook, Illinois 60062; 844-463-8734; Website: https://mdinfusions.com/
